|
1. A crystal form A solid substance of isopropyl (S)-N-(2-(pyridine-3-yl-methoxy)-4-(2-bromo-3-phenylbenzyloxy)-5-chlorobenzyl) serinate maleate, characterized in that, when powder X-ray diffraction analysis is used and Cu Target Radiation experimental conditions are adopted, the position of diffraction peak: 2-theta value (°) or d value (Å) and relative intensity (%) of diffraction peak have the following characteristics:
|
|
|
|
|
|
2-Theta |
d(Å) |
intensity % |
|
|
Peak |
±0.2° |
±0.2 Å |
±5% |
|
|
|
|
|
|
|
|
1 |
4.5 |
19.6 |
42.3 |
|
|
2 |
5.6 |
15.9 |
50.1 |
|
|
3 |
6.8 |
13.0 |
14.0 |
|
|
4 |
8.5 |
10.4 |
16.2 |
|
|
5 |
9.1 |
9.8 |
100 |
|
|
6 |
10.2 |
8.7 |
28.1 |
|
|
7 |
12.4 |
7.1 |
11.1 |
|
|
8 |
13.3 |
6.7 |
18.6 |
|
|
9 |
13.6 |
6.5 |
35.6 |
|
|
10 |
14.6 |
6.1 |
12.1 |
|
|
11 |
15.5 |
5.7 |
15 |
|
|
12 |
16.0 |
5.5 |
11 |
|
|
13 |
16.6 |
5.3 |
13.6 |
|
|
14 |
17.1 |
5.2 |
14.2 |
|
|
15 |
17.4 |
5.1 |
13.8 |
|
|
16 |
17.9 |
4.9 |
17.4 |
|
|
17 |
18.7 |
4.7 |
17.6 |
|
|
18 |
19.0 |
4.7 |
20.1 |
|
|
19 |
19.7 |
4.5 |
35.5 |
|
|
20 |
20.0 |
4.4 |
46.6 |
|
|
21 |
20.7 |
4.3 |
58.3 |
|
|
22 |
21.6 |
4.1 |
35.5 |
|
|
23 |
22.2 |
4.0 |
15 |
|
|
24 |
22.7 |
3.9 |
33.6 |
|
|
25 |
23.1 |
3.9 |
50.5 |
|
|
26 |
23.9 |
3.7 |
42 |
|
|
27 |
25.0 |
3.6 |
16.4 |
|
|
28 |
25.4 |
3.5 |
19.2 |
|
|
29 |
26.6 |
3.4 |
28 |
|
|
30 |
28.0 |
3.2 |
13.9 |
|
|
31 |
28.4 |
3.1 |
15.9 |
|
|
32 |
29.3 |
3.1 |
19.1 |
|
|
33 |
29.9 |
3.0 |
14.2 |
|
|
34 |
30.4 |
2.9 |
14.4 |
|
|
35 |
31.0 |
2.9 |
15.7 |
|
|
36 |
31.6 |
2.8 |
15.6 |
|
|
37 |
32.7 |
2.7 |
12.2 |
|
|
38 |
34.0 |
2.6 |
12.7 |
|
|
39 |
34.9 |
2.6 |
11.9 |
|
|
40 |
35.7 |
2.5 |
13.4 |
|
|
41 |
39.0 |
2.3 |
11.2 |
|
|
|
| |
|